Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-03-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于金宇生物技术股份有限公司2019年度募集资金存放与使用情况鉴证报告
Regulatory Filings
2020-03-29 Chinese
2019年度内部控制审计报告
Regulatory Filings
2020-03-29 Chinese
2019年度审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2019年度审计委员会履职情况报告" which translates to "2019 Annual Audit Committee Performance Report." It details the activities, meetings, and evaluations conducted by the audit committee during 2019, including oversight of external and internal audits, review of financial reports, and internal control assessments. The document references audit reports and financial statements but does not itself contain full financial statements or the complete annual report. It is a standalone report focused on audit committee activities and audit oversight, which aligns with the definition of an Audit Report / Information (AR). The document length is 3210 characters, which is relatively short but contains substantive content about audit committee work rather than just an announcement. Therefore, it is classified as AR with high confidence. FY 2019
2020-03-29 Chinese
第十届董事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 10th Board of Directors' 4th meeting of JinYu Biotechnology Co., Ltd. It includes approvals of the 2019 annual board work report, the 2019 annual report, financial work report, profit distribution plan, internal control evaluation report, independent directors' reports, audit committee reports, and other governance matters. It also mentions the scheduling of the 2019 annual shareholders meeting. The document is not the annual report itself but a board meeting resolution announcement that includes approval of the annual report and related documents. The document length is 2640 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of board meeting resolutions and approvals, not the full annual report or other standalone report.
2020-03-29 Chinese
独立董事关于第十届董事会第四次会议相关事项的独立意见
Regulatory Filings
2020-03-29 Chinese
关于为子公司银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing guarantees for bank credit to its subsidiaries. It details the guarantee amount, the subsidiaries involved, the board and independent directors' opinions, and other related information. There are no financial statements or comprehensive financial performance data presented. The document is relatively short (2279 characters) and serves as a formal disclosure of a corporate action related to financing support for subsidiaries. This fits the category of Capital/Financing Update (CAP), which covers updates on company financing activities or capital structure changes such as guarantees for bank credit.
2020-03-29 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.